1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,386 | 0,435 | 14.11. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Lifecare ASA: Financial calendar | 1 | Oslo Børs | ||
| LIFECARE ASA Aktie jetzt für 0€ handeln | |||||
| 05.11. | Lifecare ASA: Lifecare shares key learnings from ongoing longevity study LFC-SEN-002 | 2 | Oslo Børs | ||
| 22.10. | LIFECARE ASA: Extraordinary General Meeting | 3 | Oslo Børs | ||
| 22.10. | Lifecare ASA: Key information relating to the proposed partially underwritten rights issue | 4 | Oslo Børs | ||
| 22.10. | Lifecare ASA: Proposed partially underwritten rights issue | 2 | Oslo Børs | ||
| 26.09. | Lifecare ASA: Mandatory notification of trade | - | Oslo Børs | ||
| 24.09. | Lifecare ASA: Lifecare strengthens miniaturisation roadmap with new patent applications | 1 | Oslo Børs | ||
| 15.09. | Lifecare ASA: LIFECARE RESUBMITS APPLICATION FOR FIRST-IN-HUMAN CLINICAL STUDY | 1 | Oslo Børs | ||
| 27.08. | Lifecare ASA: Reconfirmed positive results in veterinary study support path toward market entry | 3 | Oslo Børs | ||
| 20.08. | LIFE: Lifecare ASA Q2 2025 results | 4 | Oslo Børs | ||
| 13.08. | Lifecare ASA: Lifecare advances CE mark preparation for its groundbreaking medical device | 4 | Oslo Børs | ||
| 12.08. | Lifecare ASA: Invitation to presentation of Q2 2025 results 20 August at 10.45 CEST | 3 | Oslo Børs | ||
| 05.08. | Lifecare ASA Secures REK Ethics Approval For First-In-Human CGM Trial | 2 | RTTNews | ||
| 05.08. | Lifecare ASA: Lifecare receives ethics approval to initiate first-in-human trial in Norway | 3 | Oslo Børs | ||
| 08.07. | Lifecare ASA: Lifecare achieves full radio frequency compliance for CGM implant clearing the way for CE mark of electronics | 2 | Oslo Børs | ||
| 01.07. | Lifecare ASA: Lifecare advances electromagnetic compatibility compliance testing for CGM implant | 1 | Oslo Børs | ||
| 25.06. | Lifecare ASA: Share capital increase registered | 2 | Oslo Børs | ||
| 13.06. | Lifecare ASA: Final results following expiry of the exercise period for the Warrants issued in connection with the Rights Issue | 2 | Oslo Børs | ||
| 13.06. | Lifecare ASA: Notification of trade - exercise of warrants | - | Oslo Børs | ||
| 13.06. | Lifecare ASA: Last day of the Exercise Period for the Warrants issued in connection with the Rights Issue | 1 | Oslo Børs |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 86,40 | +0,63 % | Roku Unveils Black Friday And Cyber Monday Deals Starting November 20 | WASHINGTON (dpa-AFX) - Beginning November 20, Roku Inc (ROKU) will be offering significant holiday discounts on all of its TVs, streaming devices, and smart home goods. Customers can now purchase... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,083 | -1,78 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 89,40 | +1,13 % | Boston Scientific Up 7% in a Month: How Should You Play the Stock? | ||
| PAUL HARTMANN | 224,00 | +0,45 % | Januar bis Juni 2025: PAUL HARTMANN behauptet sich in herausforderndem Marktumfeld | Heidenheim (ots) - - Umsatzerlöse steigen auf 1.214,0 Mio. EUR, organisches Umsatzwachstum von 1,6 % - Bereinigtes EBITDA liegt bei 125,8 Mio. EUR, bereinigte EBITDA-Rendite bei 10,4 % - Transformationsprogramm... ► Artikel lesen | |
| SYSMEX | 8,750 | -2,78 % | Sysmex H1 Profit Declines | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Sysmex Corporation reported that its first half profit attributable to owners of the
parent was 19.0 billion yen, a decline of 26.9% from prior year. Earnings... ► Artikel lesen | |
| ADDLIFE | 16,500 | 0,00 % | AddLife AB: Interim Report January 1 - September 30, 2025 | Good organic growth and strong earnings development"AddLife's companies performed strongly during the quarter. Organic growth was solid, margin improvement continued, earnings increased significantly... ► Artikel lesen | |
| EMBECTA | 12,500 | -0,79 % | embecta Announces Major New Commitment to Direct Relief on World Diabetes Day | Expanded Partnership Will Increase Access to Diabetes Care for Communities Across the U.S. and Globally SANTA BARBARA, CA / ACCESS Newswire / November 14, 2025 / On World Diabetes Day, embecta Corp.... ► Artikel lesen | |
| ENOVIS | 26,200 | -2,24 % | Enovis auf der UBS Global Healthcare Konferenz: Strategische Weichenstellung im Orthopädie-Sektor | ||
| KANGJI MEDICAL | 1,000 | 0,00 % | XFRA 50J: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILKANGJI MED.HLDS... ► Artikel lesen | |
| PULMONX | 1,310 | -9,66 % | Pulmonx outlines $89M-$90M 2025 guidance with renewed focus on execution and cost discipline | ||
| SI-BONE | 14,700 | -2,00 % | SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance | Delivered ~21% worldwide revenue growth, ~5% adjusted EBITDA margin, and positive cash from operating activities in the quarter Third Quarter 2025 Financial Highlights (all comparisons are to the... ► Artikel lesen | |
| KOOTH | 1,420 | -0,70 % | Kooth PLC - Transfer of Treasury Shares & Exercise of Options | ||
| PEIJIA MEDICAL | 0,620 | 0,00 % | Peijia Medical Announces 2025 Interim Results | HONG KONG, Aug. 25, 2025 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets... ► Artikel lesen | |
| BACTIGUARD | 1,375 | +0,36 % | Bactiguard Holding AB: Bactiguard Holding AB's interim report third quarter 2025 | Continued profitability and clinical evidence supporting future growth
Third quarter 2025 (July - September)
Total revenue amounted to SEK 48.4 (73.9) million, a decrease of SEK 25.5 million corresponding... ► Artikel lesen | |
| SCIBASE | 0,000 | 0,00 % | SciBase: Interim report | STOCKHOLM, Nov. 7, 2025 /PRNewswire/ --
January 1 - September 30, 2025
The third quarter in figures
Net sales were TSEK 10,339 (8,408), +23%, cleared... ► Artikel lesen |
LIFECARE ASA gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +15,36 % bei einem Aktienkurs von 0,428 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFECARE ASA finden Sie auf Wallstreet Online.